Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 5 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Featured Broker Partners


Advertisement